Kunsulu Zakariya, Advisor to the President of the Republic of Kazakhstan for Scientific and Technological Innovation (center), Akmaral Alnazarova, Minister of Health of the Republic of Kazakhstan (fifth from the left), Zholdykhan Sanat, Director of the National Institute for Innovation Development (fourth from the right), and Yin Ye, CEO of BGI Group (fifth from the right), Dr. Li Ning, Deputy General Manager of BGI Genomics (second from the right）

BGI Genomics is thrilled to announce our collaboration with Technopark Biogen to establish the Astana Genetic Center (AGC) in Astana, the vibrant capital of Kazakhstan. This state-of-the-art genetic testing laboratory marks a significant milestone in advancing genetic research and healthcare in the region.

The AGC aims to provide cutting-edge genetic testing services, driving innovation and excellence in genomics. This collaboration reflects our commitment to leveraging the power of genetics for better health outcomes and scientific advancements.

Watch the video to get an inside look at the opening ceremony and join us in celebrating this remarkable achievement!

About BGI Genomics

BGI Genomics, headquartered in Shenzhen, China, is the world's leading integrated solutions provider of precision medicine. Its services cover more than 100 countries and regions, involving more than 2,300 medical institutions and 10,000 employees worldwide. In July 2017, as a subsidiary of BGI Group, BGI Genomics (300676.SZ) officially began trading on the Shenzhen Stock Exchange.